Protagenic Therapeutics Stock Widgets and Gadgets
| PTIX Stock | USD 0.73 0.08 12.31% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- PTIX Protagenic Therapeutics
- Latest Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of 1.275 Million
- PTIX 0.73 0.08
- Low 0.66
- High 0.94
- Volume 2.4 M
- Alpha 0.55
- Beta -1.63
- Return On Equity -2.06
- Return On Asset -0.9
- Current Valuation (463.37 K)
- Shares Outstanding 6.79 M
- Shares Owned By Insiders 14.24 %
- Shares Owned By Institutions 5.76 %
- Number Of Shares Shorted 89.12 K
- Price To Earning 9.43 X
- Price To Book 6.10 X
- EBITDA (4.5 M)
- Net Income (5 M)
- Cash And Equivalents 8.87 M
- Cash Per Share 0.51 X
- Total Debt 655.25 K
- Debt To Equity 0.04 %
- Current Ratio 19.47 X
- Book Value Per Share 0.83 X
- Cash Flow From Operations (3.7 M)
- Short Ratio 1.33 X
- Earnings Per Share (1.27) X
- Target Price 4.0
- Beta 0.25
- Market Capitalization 4.04 M
- Total Asset 4.32 M
- Retained Earnings (30.78 M)
- Working Capital 3.54 M
- Current Asset 3.75 M
- Current Liabilities 736 K
- Net Asset 4.32 M
- Accumulation Distribution 711416.0
- Daily Balance Of Power 0.2857
- Rate Of Daily Change 1.12
- Day Median Price 0.8
- Day Typical Price 0.78
- Price Action Indicator (0.03)
- Period Momentum Indicator 0.08
Market Snapshot Widget Example
DAX Index Germany | 19,296 0.56 | |
Taiwan Weighted Taiwan | 22,679 1.17 | |
PSI 20 Stock Portugal | 6,415 0.36 | |
CROBEX Croatia | 3,142 0.56 | |
Budapest SE Hungary | 80,056 0.74 | |
IDX 30 Jakarta Indonesia | 451.91 1.48 | |
ISEQ 20 Price Ireland | 1,610 0.3 | |
NYSE Comp USA | 20,219 0.0045 | |
Tel Aviv 35 Israel | 2,303 0.97 | |
Coreshares Index Tracker South Afric | 1,095 0.45 | |
IPC MEXICO Mexico | 49,713 1.44 | |
KL Technology Malaysia | 59.58 1.23 | |
IBEX 35 Index Spain | 11,618 0.8 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,518 0.7 | |
SPASX Dividend Opportunities Australia | 1,681 0.93 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.38 | |
AMS Small Cap Netherlands | 1,166 1.84 | |
Oslo Exchange Mutual Norway | 1,407 1.3 | |
BEL Small Belgium | 8,051 1.19 | |
Basic Materials Brazil | 5,726 0.95 | |
Swiss Leader Price Switzerland | 1,920 0.53 | |
Fondo Mutuo ETF Chile | 1,365 0.25 | |
Athens General Comp Greece | 1,408 0.13 | |
Stock Exchange Of Thailand | 1,438 0.35 | |
PX Prague Stock Czech Repub | 1,697 1.06 | |
THE PHILIPPINE STOCK Philippines | 6,807 0.63 | |
WIG 30 Poland | 2,822 0.14 | |
BIST Electricity Turkey | 493.15 0.1 |
Investing Ideas
In addition to having Protagenic Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Protagenic Therapeutics
Compare Protagenic Therapeutics To Peers
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.